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Historical and ethical aspects of direct treatment of
the fetus
J .W. DUDENHAUSEN
During the last 2O to 25 years perinatal medicine has
developed significantly, and the main points of interest
have been the diagnosis of the well-being of the fetus.
There were only some new aspects in treatment. For in-
stance the RH disease and the intrauterine blood trans-
fusion. But the main stream of all the scientific in-
vestigations was concerned with diagnostic problems. The
technical development of sonography, fetoscopy, amnio-
centesis, amniography and fluid collection enable us to
make a prenatal diagnosis of the defects of the fetus.
And with these diagnostic possibilities we stand today
on the brink of an age when direct therapy of the fetus
can be further developed.
Although I believe that we are on the brink of a new deal·
for the fetus as a treated patient, I would like to point
out that a direct therapy for unborn infants did in fact
appear as far back as 1928, written by SCHWARCZ ( 1 ) . He
suggested transabdominal application of drugs in cases
of fetal asphyxia. This procedure - at that time daring
and as can be seen from the original, not particularly
successful - has long since been forgotten.
I am not sure that all facts reported today in this
panel will be good news to most physicians and members
of the public. But I think we have to study the oppor-
tunities for fetal treatment and we have to give enough
support to research and the number of opportunities for
fetal treatment will multiply.
In this panel discussion we all agree that direct treat-
ment of the fetus - in particular fetal surgery - in-
volves considerable ethical problems. Firstly there are
conflicts to do with the infant having a defect which
possibly can be corrected, and then on the other hand we
have the interests of the mother who has to give permis-
sion for the therapy to be done. It is very difficult
to say what the dangers of intrauterine therapy are, an'.
above all how successful the therapy is. Let us hope
that more experience during the next few years will pro-
vide the basis for correct information of parents.
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Furthermore we have the problem that for many patients
the alternative to surgery is the artificial abortion.
Let us hope that not ecclesiastical and religious atti-
tudes, moral decisions force us to consider the fetus
not as a patient.
We see another problem in the fact that good, success-
ful fetal therapy depends on diagnostic and therapeutic
research. The line between research and medical neces-
sity has certainly not yet been drawn up.
In the end one must ask oneself whether the emphasis
should be shifted from social and economic factors in
medicine to the individual problem of direct fetal
therapy. My personal view is that the individual treat-
ment of a correctable defect should be performed on an
individual as early as possible. Economic considera^ .
tions should remain in the background to the medical
decisions.
Let us look at the future of intrauterine treatment. The
more inventive diagnostic and therapeutic procedures
involve significant risks. A great deal of clinical and
laboratory experience will be required to establish
rules and guidelines which are truly safe, necessary and
possible. In the meantime it is important to maintain
a healthy scepticism towards fetal treatment. Because
a procedure can be done, does not mean that it should
be done. A fetal malformation of any type should never
be treated simply because it is there, and never by
someone unprepared for this terrible situation.
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